
司妥昔单抗与托珠单抗序贯治疗儿童特发性多中心型Castleman病1例
易萍, 张星星, 唐甜, 王英, 吴小川, 李杏芳
中国当代儿科杂志 ›› 2025, Vol. 27 ›› Issue (5) : 613-617.
司妥昔单抗与托珠单抗序贯治疗儿童特发性多中心型Castleman病1例
Sequential treatment with siltuximab and tocilizumab for childhood idiopathic multicentric Castleman disease: a case report
患儿,女,11岁,因反复发热20 d,加重伴腹胀7 d入院。入院后患儿以反复发热、淋巴结及肝脾大、多浆膜腔积液及多器官功能障碍为突出表现,结合淋巴结病理结果及临床表现确诊为特发性多中心型Castleman病-TAFRO综合征,使用司妥昔单抗联合糖皮质激素治疗后改托珠单抗维持治疗,患儿病情得到控制。因此,当患儿一旦明确为特发性多中心型Castleman病-TAFRO综合征,应尽早使用司妥昔单抗以迅速缓解病情,后可尝试改用托珠单抗进行维持治疗。
The patient, an 11-year-old girl, was admitted with recurrent fever for 20 days, worsening with abdominal distension for 7 days. Upon admission, she presented with recurrent fever, lymphadenopathy, hepatosplenomegaly, polyserositis, and multiple organ dysfunction. Lymph node pathology and clinical manifestations confirmed the diagnosis of idiopathic multicentric Castleman disease-TAFRO syndrome. Treatment with siltuximab combined with glucocorticoids was initiated, followed by maintenance therapy with tocilizumab. The patient is currently in complete clinical remission. Therefore, once a child is diagnosed with idiopathic multicentric Castleman disease -TAFRO syndrome, early use of siltuximab should be considered for rapid disease control, followed by tocilizumab for maintenance therapy.
Castleman病 / TAFRO综合征 / 司妥昔单抗 / 托珠单抗
Castleman disease / TAFRO syndrome / Siltuximab / Tocilizumab
1 |
中华医学会血液学分会淋巴细胞疾病学组, 中国抗癌协会血液肿瘤专业委员会, 中国CASTLEMAN病协作组. 中国Castleman病诊断与治疗专家共识(2021年版)[J]. 中华血液学杂志, 2021, 42(7): 529-534. PMCID: PMC8408489. DOI: 10.3760/cma.j.issn.0253-2727.2021.07.001 .
|
2 |
|
3 |
|
4 |
|
5 |
|
6 |
|
7 |
|
8 |
|
9 |
张路, 李剑. 罕见病Castleman病的靶向治疗药物司妥昔单抗[J]. 中国医药导刊, 2022, 24(4): 299-304. DOI: 10.3969/j.issn.1009-0959.2022.04.001 .
|
10 |
刘海玲, 范磊, 李建勇. Castleman病的诊疗进展[J]. 中华血液学杂志, 2020, 41(8): 697-700. PMCID: PMC7525180. DOI: 10.3760/cma.j.issn.0253-2727.2020.08.017 .
|
11 |
|
12 |
|
13 |
|
14 |
|
15 |
陈航, 朱俪, 丁胜男, 等. 司妥昔单抗/托珠单抗治疗HHV-8阴性多中心型Castleman病的疗效及安全性单中心回顾性分析[J]. 中国医药指南, 2024, 22(31): 44-47. DOI: 10.15912/j.issn.1671-8194.2024.31.013 .
|
易萍负责数据收集、整理和分析、论文撰写;张星星负责文章的构思、设计与修改;唐甜、王英负责辅助数据收集、整理和分析;李杏芳及吴小川负责文章最终提供修改意见。